Twitter | Search | |
Search Refresh
Omnica Biotech Mar 25
industry is big on oncology claims (>5% of clinical trials with cannabinoids are aimed at cancer), but oncology is not big on cannabis (<0.1% investigated drugs are cannabinoid) Dr Alejandro Berlin emphasizes the need for quality research
Reply Retweet Like
Avicanna Inc. Mar 27
On behalf of the Avicanna team, thank you to all the attendees who joined us at our 2nd annual International Symposium! We extend our appreciation to our moderators, experts & panelists both here at home, & those who traveled to Toronto to share their expertise w/ us
Reply Retweet Like
Michael Freeman πŸ‡¨πŸ‡¦ Mar 25
Thinking critically about what makes the plant valuable: its constituent molecules. Diverse sources of these active ingredients (APIs) are the of this industry. - , Alan Ridgeway, David Kideckel, & Ignatio Peralta
Reply Retweet Like
Michael Freeman πŸ‡¨πŸ‡¦ Mar 25
Canada's world-leading climate could be this country's chance to reinvigorate its high-talent, low-action industry. - CEO, Aras Azadian
Reply Retweet Like
Avicanna Inc. Mar 25
Dr. Berlin talks with pre-clinical studies supporting the use of cannabinoids, but also highlights the opportunity for more robust data in & . Dr. Berlin with our Dr. J. Grant, Dr. Z. Koren & Dr. C. Buitrago
Reply Retweet Like
Ashton A. Abrahams Mar 25
Reply Retweet Like
Omnica Biotech Mar 25
, director of pain services at Toronto General Hospital recognizes as an option for pain management, says finding herbal products is a guessing game. Urges industry to develop cannabinoid medications that are consistent, reliable and effective
Reply Retweet Like
Benzinga Cannabis Mar 25
Reply Retweet Like
Benzinga Cannabis Mar 25
Our Managing Director is moderating a panel on Canada's role in the global market at 's feat. 's Michael Astone, PharmD (fmr. ), Alan Friedman of Bayline Capital & Aras Azadian Cc.
Reply Retweet Like
Avicanna Inc. Apr 4
β€œJust because a product has been approved for sale does not mean it is either safe or effective in treating certain medical conditions". Thank you for featuring crucial discussions from by our CSO & other speakers:
Reply Retweet Like
Dr. Christine Allen πŸ‡¨πŸ‡¦ Mar 24
Legal and natural is not necessarily safe and effective. We need to be proactive about the quality and safety of products and consumer education. A sneak peek into my keynote remarks at symposium tomorrow.
Reply Retweet Like
Andres F Zuluaga Mar 25
Summary of data in dermatology using medical cannabis by Dr Elena Pope ⁦⁦⁩ ⁦⁩
Reply Retweet Like
Andres F Zuluaga Mar 25
Today in the Symposium of the emergence of Biopharmaceutical cannabinoids on Toronto I was participating as member of
Reply Retweet Like
Sigma Analytical Services Mar 25
Excellent presentation by Aras Azadian, CEO of Avicanna Inc. at the International Symposium on Cannabinoids & Medical Applications.
Reply Retweet Like
Michael Freeman πŸ‡¨πŸ‡¦ Mar 25
CEO, Aras Azadian, on Canada's leadership in the global market: "This is not just a lead for Canadian cannabis companies and capital markets, but a lead for Canadian cannabis ." will bring this industry forward.
Reply Retweet Like
dicentra Mar 25
Don't miss our very own clinical specialist and medical liaison Dr. Edith Gorecki presenting at the Symposium on the Canadian Landscape TODAY at 10:50am!
Reply Retweet Like
Dr. Christine Allen πŸ‡¨πŸ‡¦ Mar 25
Good science is required for the sustainable success of products. It was my pleasure to deliver the keynote remarks at 's symposium. Looking forward to an exciting day of learning about medical research and clinical applications.
Reply Retweet Like